Abstract
Chondrocytes and adipocytes are two differentiated cell types which are both derived from mesenchymal cells. The purpose of this study was to investigate whether peroxisome proliferator-activated receptor-
Chondrocytes and adipocytes are two differentiated cell types which are both derived from mesenchymal cells. The purpose of this study was to investigate whether peroxisome proliferator-activated receptor-
R T Ballock and R J O'Keefe, “Physiology and pathophysiology of the growth plate,” Birth Defects Research Part C: Embryo Today: Reviews, vol. 69, no. 2, pp. 123–143, 2003.
View at: Google ScholarR S Tuan, G Boland, and R Tuli, “Adult mesenchymal stem cells and cell-based tissue engineering,” Arthritis Research and Therapy, vol. 5, no. 1, pp. 32–45, 2003.
View at: Google ScholarB de Crombrugghe, V Lefebvre, R R Behringer, W Bi, S Murakami, and W Huang, “Transcriptional mechanisms of chondrocyte differentiation,” Matrix Biology, vol. 19, no. 5, pp. 389–394, 2000.
View at: Google ScholarT Komori, “Runx2, a multifunctional transcription factor in skeletal development,” Journal of Cellular Biochemistry, vol. 87, no. 1, pp. 1–8, 2002.
View at: Google ScholarE D Rosen, C J Walkey, P Puigserver, and B M Spiegelman, “Transcriptional regulation of adipogenesis,” Genes & Development, vol. 14, no. 11, pp. 1293–1307, 2000.
View at: Google ScholarD D Jr Diascro, R L Vogel, T E Johnson et al., “High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells,” Journal of Bone and Mineral Research, vol. 13, no. 1, pp. 96–106, 1998.
View at: Google ScholarB Lecka-Czernik, I Gubrij, E J Moerman et al., “Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR2,” Journal of Cellular Biochemistry, vol. 74, no. 3, pp. 357–371, 1999.
View at: Google ScholarT Akune, S Ohba, S Kamekura et al., “PPAR insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors,” The Journal of Clinical Investigation, vol. 113, no. 6, pp. 846–855, 2004.
View at: Google ScholarK Heermeier, P G Strauss, V Erfle, and J Schmidt, “Adipose differentiation of cartilage in vitro,” Differentiation, vol. 56, no. 1-2, pp. 45–53, 1994.
View at: Google ScholarY Y Shao, L Wang, D G Hicks, S Tarr, and R T Ballock, “Expression and activation of peroxisome proliferator-activated receptors in growth plate chondrocytes,” Journal of Orthopaedic Research, vol. 23, no. 5, pp. 1139–1145, 2005.
View at: Google ScholarL Wang, Y Y Shao, and R T Ballock, “Peroxisome proliferator activated receptor- (PPAR) represses thyroid hormone signaling in growth plate chondrocytes,” Bone, vol. 37, no. 3, pp. 305–312, 2005.
View at: Google ScholarR T Ballock and A H Reddi, “Thyroxine is the serum factor that regulates morphogenesis of columnar cartilage from isolated chondrocytes in chemically defined medium,” Journal of Cell Biology, vol. 126, no. 5, pp. 1311–1318, 1994.
View at: Google ScholarY Park, B D Freedman, E J Lee, S Park, and J L Jameson, “A dominant negative PPAR mutant shows altered cofactor recruitment and inhibits adipogenesis in 3T3-L1 cells,” Diabetologia, vol. 46, no. 3, pp. 365–377, 2003.
View at: Google ScholarW Horton, T Miyashita, K Kohno, J R Hassell, and Y Yamada, “Identification of a phenotype-specific enhancer in the first intron of the rat collagen II gene,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 24, pp. 8864–8868, 1987.
View at: Google ScholarK Bohme, M Conscience-Egli, T Tschan, K H Winterhalter, and P Bruckner, “Induction of proliferation or hypertrophy of chondrocytes in serum-free culture: the role of insulin-like growth factor-I, insulin, or thyroxine,” Journal of Cell Biology, vol. 116, no. 4, pp. 1035–1042, 1992.
View at: Google ScholarW M Burch and H E Lebovitz, “Triiodothyronine stimulates maturation of porcine growth-plate cartilage in vitro,” Journal of Clinical Investigation, vol. 70, no. 3, pp. 496–504, 1982.
View at: Google ScholarA Carrascosa, M A Ferrandez, L Audi, and A Ballabriga, “Effects of triiodothyronine (T3) and identification of specific nuclear T3-binding sites in cultured human fetal epiphyseal chondrocytes,” Journal of Clinical Endocrinology and Metabolism, vol. 75, no. 1, pp. 140–144, 1992.
View at: Google ScholarJ M Lehmann, L B Moore, T A Smith-Oliver, W O Wilkison, T M Willson, and S A Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor (PPAR),” Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995.
View at: Google ScholarJ L Kelsey, R M Acheson, and K J Keggi, “The body build of patients with slipped capital femoral epiphysis,” American Journal of Diseases of Children, vol. 124, no. 2, pp. 276–281, 1972.
View at: Google ScholarK H Sorensen, “Slipped upper femoral epiphysis. Clinical study on aetiology,” Acta Orthopaedica Scandinavica, vol. 39, no. 4, pp. 499–517, 1968.
View at: Google ScholarR T Loder, “Slipped capital femoral epiphysis,” American Family Physician, vol. 57, no. 9, pp. 2135–2142, 2148–2150, 1998.
View at: Google Scholar